Sang‐Yoon Park

4.2k total citations
108 papers, 2.5k citations indexed

About

Sang‐Yoon Park is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Sang‐Yoon Park has authored 108 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Reproductive Medicine, 50 papers in Obstetrics and Gynecology and 34 papers in Surgery. Recurrent topics in Sang‐Yoon Park's work include Ovarian cancer diagnosis and treatment (57 papers), Endometrial and Cervical Cancer Treatments (47 papers) and Cervical Cancer and HPV Research (19 papers). Sang‐Yoon Park is often cited by papers focused on Ovarian cancer diagnosis and treatment (57 papers), Endometrial and Cervical Cancer Treatments (47 papers) and Cervical Cancer and HPV Research (19 papers). Sang‐Yoon Park collaborates with scholars based in South Korea, United States and Ethiopia. Sang‐Yoon Park's co-authors include Sokbom Kang, Sang‐Soo Seo, Myong Cheol Lim, Jae‐Weon Kim, Sun Lee, Seung Bae Rho, Hyuck Jae Choi, Ju‐Won Roh, Jeong‐Yeol Park and Joo‐Young Kim and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Sang‐Yoon Park

100 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sang‐Yoon Park South Korea	27	1.2k	1.1k	701	550	461	108	2.5k
Andrea Papadia Italy	30	1.4k 1.2×	1.1k 1.1×	453 0.6×	587 1.1×	470 1.0×	131	2.5k
Mauro Signorelli Italy	30	1.7k 1.4×	1.5k 1.4×	525 0.7×	473 0.9×	515 1.1×	95	2.8k
Hee‐Sug Ryu South Korea	27	1.3k 1.1×	1.1k 1.0×	694 1.0×	502 0.9×	403 0.9×	110	2.5k
Anna Myriam Perrone Italy	26	947 0.8×	912 0.9×	386 0.6×	211 0.4×	346 0.8×	165	2.4k
Pierandrea De Iaco Italy	35	1.9k 1.6×	1.8k 1.7×	1.1k 1.6×	262 0.5×	504 1.1×	197	3.6k
Desmond P.J. Barton United Kingdom	28	837 0.7×	968 0.9×	1.1k 1.5×	425 0.8×	648 1.4×	99	2.5k
Vanna Zanagnolo Italy	34	2.1k 1.8×	1.8k 1.7×	1.3k 1.9×	655 1.2×	643 1.4×	124	3.5k
Bengt Sorbe Sweden	30	1.6k 1.3×	1.5k 1.4×	761 1.1×	467 0.8×	634 1.4×	133	3.0k
John H. Shepherd United Kingdom	28	1.5k 1.2×	1.4k 1.3×	798 1.1×	626 1.1×	745 1.6×	66	3.1k
J. H. Shepherd United Kingdom	25	821 0.7×	785 0.7×	642 0.9×	334 0.6×	477 1.0×	88	2.0k

Countries citing papers authored by Sang‐Yoon Park

Since Specialization

Citations

This map shows the geographic impact of Sang‐Yoon Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang‐Yoon Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang‐Yoon Park more than expected).

Fields of papers citing papers by Sang‐Yoon Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sang‐Yoon Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang‐Yoon Park. The network helps show where Sang‐Yoon Park may publish in the future.

Co-authorship network of co-authors of Sang‐Yoon Park

This figure shows the co-authorship network connecting the top 25 collaborators of Sang‐Yoon Park. A scholar is included among the top collaborators of Sang‐Yoon Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sang‐Yoon Park. Sang‐Yoon Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kang, Mingyeong, Seeyoun Lee, Han‐Sung Kang, et al.. (2025). PALB2 germline pathogenic variants: frequency, clinical features, and functional analysis of c.3350+5G>A variant in 3987 Korean cancer patients. ESMO Open. 10(3). 104132–104132.

Chang, Yoon Jung, Sun‐Young Kong, Chong Woo Yoo, et al.. (2024). The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation. Journal of Gynecologic Oncology. 36(2). e15–e15.

Shim, Hyoeun, et al.. (2024). Preoperative laboratory parameters associated with deep vein thrombosis in patients with ovarian cancer: retrospective analysis of 3,147 patients in a single institute. Journal of Gynecologic Oncology. 35(4). e38–e38. 2 indexed citations

Seo, Sang Soo, et al.. (2024). Docetaxel/Cisplatin Chemotherapy Followed by Pelvic Radiation Therapy in Patients With High-risk Endometrial Cancer After Staging Surgery: A Phase 2 Study. International Journal of Radiation Oncology*Biology*Physics. 121(5). 1229–1236.

Lee, Yumi, Sinae Kim, Sang‐Soo Seo, et al.. (2023). Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey. Journal of Gynecologic Oncology. 35(1). e3–e3. 2 indexed citations

Park, Meerim, Jun Ah Lee, Hyeon Jin Park, et al.. (2023). Excellent Outcomes in Children, Adolescents, and Young Adults with Ovarian Germ Cell Tumors Treated by Either Reduced- or Standard-Dose Bleomycin. Cancers. 15(21). 5290–5290. 1 indexed citations

Shin, Wonkyo, Sang‐Yoon Park, Sokbom Kang, et al.. (2022). A predictive model based on site-specific risk factors of recurrence regions in endometrial cancer patients. BMC Cancer. 22(1). 1111–1111. 1 indexed citations

Shin, Wonkyo, Sang‐Yoon Park, Sokbom Kang, Myong Cheol Lim, & Sang‐Soo Seo. (2021). How to manage synchronous endometrial and ovarian cancer patients?. BMC Cancer. 21(1). 489–489. 6 indexed citations

Shin, Wonkyo, et al.. (2021). The Knowledge and Attitude of Patients Diagnosed with Epithelial Ovarian Cancer towards Genetic Testing. International Journal of Environmental Research and Public Health. 18(5). 2312–2312. 2 indexed citations

10.

Park, Jongmoo, Yeon-Joo Kim, Yeon-Joo Kim, et al.. (2021). Definitive Chemoradiotherapy versus Radical Hysterectomy Followed by Tailored Adjuvant Therapy in Women with Early-Stage Cervical Cancer Presenting with Pelvic Lymph Node Metastasis on Pretreatment Evaluation: A Propensity Score Matching Analysis. Cancers. 13(15). 3703–3703. 14 indexed citations

11.

Shin, Wonkyo, Joseph J. Noh, Sang‐Soo Seo, et al.. (2020). Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer. Yonsei Medical Journal. 61(11). 935–935. 1 indexed citations

12.

Kim, Miseon, Byung Su Kwon, Ha Kyun Chang, et al.. (2019). Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study. Journal of Gynecologic Oncology. 30(3). e44–e44. 11 indexed citations

13.

Park, Soo Jin, Jihye Kim, Hee Seung Kim, et al.. (2019). Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study. Journal of Gynecologic Oncology. 31(2). e15–e15. 5 indexed citations

14.

Paik, E Sun, Yong Jae Lee, Jung‐Yun Lee, et al.. (2019). Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study. Journal of Clinical Medicine. 8(11). 1920–1920. 9 indexed citations

15.

Chang, Jee Suk, Sang Wun Kim, Yeon-Joo Kim, et al.. (2018). Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial. Gynecologic Oncology. 151(1). 39–45. 24 indexed citations

16.

Kim, Jin Hee, Jin Hee Kim, Joo‐Young Kim, et al.. (2016). Prophylactic irradiation of para-aortic lymph nodes for patients with locally advanced cervical cancers with and without high CA9 expression (KROG 07-01): A randomized, open-label, multicenter, phase 2 trial. Radiotherapy and Oncology. 120(3). 383–389. 21 indexed citations

17.

Suh, Dong Hoon, Jeong‐Yeol Park, Jung‐Yun Lee, et al.. (2015). The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study. Gynecologic Oncology. 137(3). 412–417. 16 indexed citations

18.

Roh, Ju‐Won, Dong Ock Lee, Dong Hoon Suh, et al.. (2015). Efficacy and oncologic safety of nerve-sparing radical hysterectomy for cervical cancer: a randomized controlled trial. Journal of Gynecologic Oncology. 26(2). 90–90. 50 indexed citations

19.

Kang, Sokbom, Jong‐Min Lee, Jae Kwan Lee, et al.. (2014). A Web-Based Nomogram Predicting Para-aortic Nodal Metastasis in Incompletely Staged Patients With Endometrial Cancer. International Journal of Gynecological Cancer. 24(3). 513–519. 13 indexed citations

20.

Kang, Sokbom, Woong Ju, Jae‐Weon Kim, et al.. (2006). Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer. Experimental & Molecular Medicine. 38(3). 320–324. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact